• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非雌激素类及补充疗法治疗更年期。

Non-oestrogen-based and complementary therapies for menopause.

机构信息

Beginnings Assisted Conception Unit, Epsom and St Helier University Hospitals, London, UK; Comprehensive Clinical Trials Unit, Institute for Clinical Trials and Methodology, University College London, London, UK.

Reproductive Medicine Unit, University College London Hospital, London, UK.

出版信息

Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101819. doi: 10.1016/j.beem.2023.101819. Epub 2023 Aug 25.

DOI:10.1016/j.beem.2023.101819
PMID:37659918
Abstract

Women are living a significant portion of their adult lives in the post-reproductive phase, and many seek help for debilitating menopausal symptoms. Every individual's experience of menopausal transition is unique. Adopting a holistic approach to managing the menopause using a combination of lifestyle, hormonal, and non-hormonal interventions is key to maximise the quality of life of affected women. However, many opt to use non hormonal options or have contraindications to using hormonal therapy. Studies have shown that several pharmacological non-hormonal medications such as SSRIs, SSRI/SNRIs, Gabapentin, and Pregabalin are effective for managing vasomotor symptoms as well as other menopausal symptoms. Their main side effects are dry mouth, nausea, constipation, reduced libido, and loss of appetite. Clonidine is the only non-hormonal drug which is licenced for control of vasomotor symptoms in the UK, but has several side effects including dizziness and sleep disturbance. Cognitive Behavioural Therapy is recommended as a treatment for anxiety, sleep problems and vasomotor symptoms related to menopausal transition. Evidence for clinical efficacy and safety of herbal remedies and alternative therapies remains weak. Studies with neurokinin receptor 3 antagonists on women with hot flushes have shown improvement in vasomotor symptoms and results of large-scale studies are awaited.

摘要

女性在成年后的很大一部分时间都处于绝经后阶段,许多人因绝经相关的衰弱症状寻求帮助。每个人的绝经过渡体验都是独特的。采用整体方法,通过生活方式、激素和非激素干预措施相结合来管理绝经,是提高受影响女性生活质量的关键。然而,许多人选择使用非激素方法,或者对激素治疗有禁忌症。研究表明,几种药理学非激素药物,如 SSRIs、SSRIs/SNRIs、加巴喷丁和普瑞巴林,对管理血管舒缩症状以及其他绝经症状都有效。它们的主要副作用是口干、恶心、便秘、性欲降低和食欲不振。可乐定是唯一在英国获准用于控制血管舒缩症状的非激素药物,但有几个副作用,包括头晕和睡眠障碍。认知行为疗法被推荐作为治疗焦虑、睡眠问题和与绝经过渡相关的血管舒缩症状的方法。草药和替代疗法的临床疗效和安全性证据仍然薄弱。对患有热潮红的女性使用神经激肽受体 3 拮抗剂的研究表明,血管舒缩症状有所改善,正在等待大规模研究的结果。

相似文献

1
Non-oestrogen-based and complementary therapies for menopause.非雌激素类及补充疗法治疗更年期。
Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101819. doi: 10.1016/j.beem.2023.101819. Epub 2023 Aug 25.
2
EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms.欧洲更年期与男性更年期协会立场声明:更年期血管舒缩症状的非激素管理
Maturitas. 2015 Jul;81(3):410-3. doi: 10.1016/j.maturitas.2015.04.009. Epub 2015 Apr 22.
3
Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.加巴喷丁和普瑞巴林治疗血管舒缩症状患者的疗效和安全性:系统评价和荟萃分析。
Am J Obstet Gynecol. 2020 Jun;222(6):564-579.e12. doi: 10.1016/j.ajog.2019.12.011. Epub 2019 Dec 20.
4
Treatment of Vasomotor Symptoms.血管舒缩症状的治疗
J Am Board Fam Med. 2024 Sep-Oct;37(5):923-932. doi: 10.3122/jabfm.2023.230408R1.
5
Assessment and treatment of hot flushes and menopausal mood disturbance.潮热及绝经相关情绪障碍的评估与治疗
Psychiatr Clin North Am. 2003 Sep;26(3):563-80. doi: 10.1016/s0193-953x(03)00045-5.
6
[HTA and non-hormonal menopause treatment].[卫生技术评估与非激素绝经治疗]
Presse Med. 2019 Nov;48(11 Pt 1):1284-1287. doi: 10.1016/j.lpm.2019.07.002. Epub 2019 Aug 28.
7
Non-hormonal pharmacological interventions for managing vasomotor symptoms-how can we help: 2024 landscape.非激素药理学干预措施管理血管舒缩症状——我们能如何提供帮助:2024 年前景。
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:141-148. doi: 10.1016/j.ejogrb.2024.09.013. Epub 2024 Sep 12.
8
Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors.乳腺癌幸存者绝经期血管舒缩症状管理的非药物治疗。
Support Care Cancer. 2021 Mar;29(3):1183-1193. doi: 10.1007/s00520-020-05754-w. Epub 2020 Sep 17.
9
Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.更年期血管舒缩症状的心理社会和社会经济负担:一项综合综述
Health Qual Life Outcomes. 2005 Aug 5;3:47. doi: 10.1186/1477-7525-3-47.
10
Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.选择性5-羟色胺再摄取抑制剂(SSRIs)和5-羟色胺-去甲肾上腺素再摄取抑制剂(SNRIs)能否降低绝经后女性潮热的频率和/或严重程度?
J Okla State Med Assoc. 2017 May;110(5):272-274.

引用本文的文献

1
The Effect of Curcumin on Postmenopausal Symptoms: A Systematic Review Based on Randomized Controlled Trials.姜黄素对绝经后症状的影响:基于随机对照试验的系统评价
Int J Mol Sci. 2025 Aug 26;26(17):8260. doi: 10.3390/ijms26178260.
2
Analysis of Menopausal Hormone Therapy to Chinese Patients with Menopausal Syndrome: A Real-World Retrospective Study from Chinese Hospitals.中国绝经综合征患者的绝经激素治疗分析:一项来自中国医院的真实世界回顾性研究
Drug Des Devel Ther. 2025 Jun 4;19:4861-4873. doi: 10.2147/DDDT.S517420. eCollection 2025.